Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Colorectal Neoplasms

  Free Subscription


17.02.2020

1 Adv Exp Med Biol
1 Am J Clin Oncol
1 Am J Surg
5 Ann Surg Oncol
5 BMC Cancer
2 Cancer Lett
1 Clin Cancer Res
1 Dis Colon Rectum
2 Gastroenterology
2 Gastrointest Endosc
1 Gut
3 Int J Cancer
1 Int J Colorectal Dis
1 J Natl Cancer Inst
1 J Surg Oncol
1 N Engl J Med
1 Oncogene
1 PLoS Biol
1 PLoS Comput Biol
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Exp Med Biol

  1. LEMAN JKH, Munoz-Erazo L, Kemp RA
    The Intestinal Tumour Microenvironment.
    Adv Exp Med Biol. 2020;1226:1-22.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  2. WEGNER RE, Abel S, Hasan S, White RJ, et al
    Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.
    Am J Clin Oncol. 2019;42:519-526.
    PubMed     Text format     Abstract available


    Am J Surg

  3. LEE SY, Yeom SS, Kim CH, Kim HR, et al
    Nutritional risk screening score is associated with omission of adjuvant chemotherapy for stage III colon cancer.
    Am J Surg. 2020 Feb 7. pii: S0002-9610(20)30083.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  4. JEDDOU H, Tzedakis S, Sulpice L, Boudjema K, et al
    Resection of the Dorsal Sector of the Liver: The Anterior Transhepatic Approach.
    Ann Surg Oncol. 2019;26:3681.
    PubMed     Text format     Abstract available

  5. RIBI K, Marti WR, Bernhard J, Grieder F, et al
    Quality of Life After Total Mesorectal Excision and Rectal Replacement: Comparing Side-to-End, Colon J-Pouch and Straight Colorectal Reconstruction in a Randomized, Phase III Trial (SAKK 40/04).
    Ann Surg Oncol. 2019;26:3568-3576.
    PubMed     Text format     Abstract available

  6. WANG YY, Liu ZZ, Xu D, Liu M, et al
    Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2019;26:3682-3692.
    PubMed     Text format     Abstract available

  7. BOEDING JRE, Schreinemakers JMJ
    ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
    Ann Surg Oncol. 2020 Feb 11. pii: 10.1245/s10434-020-08250.
    PubMed     Text format    

  8. IMAIZUMI K, Nishizawa Y, Ikeda K, Tsukada Y, et al
    Prognostic Impact of Curative Resection for Peritoneal Recurrence of Colorectal Cancer.
    Ann Surg Oncol. 2020 Feb 12. pii: 10.1245/s10434-020-08242.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. MIZUSHIMA T, Ikeda M, Kato T, Ikeda A, et al
    Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.
    BMC Cancer. 2019;19:929.
    PubMed     Text format     Abstract available

  10. SAVOIE MB, Laffan A, Brickman C, Daniels B, et al
    A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer.
    BMC Cancer. 2019;19:906.
    PubMed     Text format     Abstract available

  11. FERNANDEZ-BANARES F, Cleries R, Boadas J, Ribes J, et al
    Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study).
    BMC Cancer. 2019;19:734.
    PubMed     Text format     Abstract available

  12. TANABE T, Shida D, Komukai S, Nakamura Y, et al
    Long-term outcomes after surgical dissection of inguinal lymph node metastasis from rectal or anal canal adenocarcinoma.
    BMC Cancer. 2019;19:733.
    PubMed     Text format     Abstract available

  13. PERROTT S, Laurie K, Laws K, Johnes A, et al
    Young-onset colorectal cancer in the North East of Scotland: survival, clinico-pathological features and genetics.
    BMC Cancer. 2020;20:108.
    PubMed     Text format     Abstract available


    Cancer Lett

  14. XIAO YW, Zhong JN, Zhong BY, Huang JY, et al
    Exosomes as potential sources of biomarkers in colorectal cancer.
    Cancer Lett. 2020 Feb 7. pii: S0304-3835(20)30047.
    PubMed     Text format     Abstract available

  15. LEE WK, Thevenod F
    Oncogenic PITX2 facilitates tumor cell drug resistance by inverse regulation of hOCT3/SLC22A3 and ABC drug transporters in colon and kidney cancers.
    Cancer Lett. 2019;449:237-251.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  16. MIDDLETON G, Yang Y, Campbell CD, Andre T, et al
    BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer.
    Clin Cancer Res. 2020 Feb 11. pii: 1078-0432.CCR-19-3579.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  17. PATEL SV, Zhang L, Wei XS, Merchant SJ, et al
    A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
    Dis Colon Rectum. 2020;63:336-345.
    PubMed     Text format     Abstract available


    Gastroenterology

  18. GU S, Zaidi S, Hassan MI, Mohammad T, et al
    Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.
    Gastroenterology. 2020;158:238-252.
    PubMed     Text format     Abstract available

  19. GUPTA S, Lieberman D, Anderson JC, Burke CA, et al
    Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.
    Gastroenterology. 2020 Feb 5. pii: S0016-5085(19)41479.
    PubMed     Text format    


    Gastrointest Endosc

  20. MACPHAIL ME, Thygesen SB, Patel N, Broadley HM, et al
    Endoscopic control of polyp burden and expansion of surveillance intervals in serrated polyposis syndrome.
    Gastrointest Endosc. 2019;90:96-100.
    PubMed     Text format     Abstract available

  21. GUPTA S, Lieberman D, Anderson JC, Burke CA, et al
    Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.
    Gastrointest Endosc. 2020 Feb 3. pii: S0016-5107(20)30036.
    PubMed     Text format    


    Gut

  22. YEOH YK, Chen Z, Wong MCS, Hui M, et al
    Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor.
    Gut. 2020 Feb 12. pii: gutjnl-2019-319635. doi: 10.1136/gutjnl-2019-319635.
    PubMed     Text format     Abstract available


    Int J Cancer

  23. LIN Y, Ma C, Bezabeh T, Wang Z, et al
    (1) H NMR-based metabolomics reveal overlapping discriminatory metabolites and metabolic pathway disturbances between colorectal tumor tissues and fecal samples.
    Int J Cancer. 2019;145:1679-1689.
    PubMed     Text format     Abstract available

  24. MPUNGA T, Umulisa MC, Tenet V, Rugwizangoga B, et al
    Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
    Int J Cancer. 2019 Jun 7. doi: 10.1002/ijc.32491.
    PubMed     Text format     Abstract available

  25. LOPES A, Billard E, Casse AH, Villeger R, et al
    Colibactin-positive E. coli induce a pro-carcinogenic immune environment leading to immunotherapy resistance in colorectal cancer.
    Int J Cancer. 2020 Feb 9. doi: 10.1002/ijc.32920.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  26. SAITO H, Kudo SE, Takahashi N, Yamamoto S, et al
    Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).
    Int J Colorectal Dis. 2020 Feb 7. pii: 10.1007/s00384-020-03518.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  27. CHANG GJ, You YNY, Russell CA, Tierno MB, et al
    Young-Onset Colon Cancer and Recurrence Risk By Gene Expression.
    J Natl Cancer Inst. 2020 Feb 10. pii: 5732656. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Surg Oncol

  28. SERRANO PE, Gu CS, Moulton CA, Husien M, et al
    Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
    J Surg Oncol. 2020 Feb 7. doi: 10.1002/jso.25864.
    PubMed     Text format     Abstract available


    N Engl J Med

  29. SCHAEFER JK, Ramnath N
    Fluorouracil-Induced Hyperpigmentation.
    N Engl J Med. 2020;382:e6.
    PubMed     Text format    


    Oncogene

  30. ROHWER N, Jumpertz S, Erdem M, Egners A, et al
    Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.
    Oncogene. 2019;38:5670-5685.
    PubMed     Text format     Abstract available


    PLoS Biol

  31. CHEN Y, Vandereyken M, Newton IP, Moraga I, et al
    Loss of adenomatous polyposis coli function renders intestinal epithelial cells resistant to the cytokine IL-22.
    PLoS Biol. 2019;17:e3000540.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  32. KHAKABIMAMAGHANI S, Ding D, Snow O, Ester M, et al
    Uncovering the subtype-specific temporal order of cancer pathway dysregulation.
    PLoS Comput Biol. 2019;15:e1007451.
    PubMed     Text format     Abstract available


    PLoS One

  33. YAMAJI T, Iwasaki M, Sawada N, Shimazu T, et al
    Fat mass and obesity-associated gene polymorphisms, pre-diagnostic plasma adipokine levels and the risk of colorectal cancer: The Japan Public Health Center-based Prospective Study.
    PLoS One. 2020;15:e0229005.
    PubMed     Text format     Abstract available

  34. OLSSON L, Hammarstrom ML, Israelsson A, Lindmark G, et al
    Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis.
    PLoS One. 2020;15:e0229007.
    PubMed     Text format     Abstract available

  35. LV Y, Duanmu J, Fu X, Li T, et al
    Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    PLoS One. 2020;15:e0228575.
    PubMed     Text format     Abstract available

  36. DARBA J, Marsa A
    Results after 10 years of colorectal cancer screenings in Spain: Hospital incidence and in-hospital mortality (2011-2016).
    PLoS One. 2020;15:e0228795.
    PubMed     Text format     Abstract available

  37. JUROWICH C, Lichthardt S, Kastner C, Haubitz I, et al
    Laparoscopic versus open right hemicolectomy in colon carcinoma: A propensity score analysis of the DGAV StuDoQ|ColonCancer registry.
    PLoS One. 2019;14:e0218829.
    PubMed     Text format     Abstract available

  38. RABIN-COURT A, Rodrigues MR, Zhang XM, Perry RJ, et al
    Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
    PLoS One. 2019;14:e0218126.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: